| Field | Row 1 |
|---|---|
| adsh | 0001641172-25-009392 |
| cik | 1572386 |
| name | GREENWAY TECHNOLOGIES INC |
| sic | 2090 |
| countryba | US |
| stprba | TX |
| cityba | ARLINGTON |
| zipba | 76011 |
| bas1 | 1521 NORTH COOPER STREET |
| bas2 | SUITE 205 |
| baph | (561) 809-4644 |
| countryma | US |
| stprma | TX |
| cityma | ARLINGTON |
| zipma | 76011 |
| mas1 | 1521 NORTH COOPER STREET |
| mas2 | SUITE 205 |
| countryinc | US |
| stprinc | TX |
| ein | 900893594 |
| former | UMED HOLDINGS, INC. |
| changed | 20130318 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250509 |
| accepted | 2025-05-09 13:42:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10-q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009392 | 20250331 | Convertible Notes Payable Current | 166667.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock Shares Issued | 445327871.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock Shares Outstanding | 445327871.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Increase Decrease In Customer Deposits | 310000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Liabilities And Stockholders Equity | 20251.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Liabilities Current | 13026700.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Liabilities Current | 13435546.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Net Cash Provided By Used In Financing Activities | 650.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Net Cash Provided By Used In Operating Activities | -1782.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Net Income Loss | -357071.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20250331 | Nonoperating Income Expense | -151499.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= In Default; | ||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 525000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable One; | ||
| 0001641172-25-009392 | 20250331 | Other Liabilities Current | 2500.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Prepaid Expense And Other Assets Current | 51624.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Proceeds From Issuance Of Common Stock | 476000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Research And Development Expense | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20231231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | |||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | -13006449.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | 43085.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | -39373172.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | -13214090.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Subscription Receivable | -99000.0000 | USD | 0 | 0001641172-25-009392 | |||
| 0001641172-25-009392 | 20241231 | Accounts Payable And Accrued Liabilities Current | 5232823.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-009392 | 20250331 | Accounts Payable And Accrued Liabilities Current | 5255086.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-009392 | 20250331 | Additional Paid In Capital Common Stock | 26877189.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock To Be Issued | 20000.0000 | USD | 0 | 0001641172-25-009392 | |||
| 0001641172-25-009392 | 20250331 | Convertible Notes Payable Current | 166667.0000 | USD | 0 | us-gaap/2024 | Short Term Debt Type= Convertible Notes Payable; | ||
| 0001641172-25-009392 | 20240331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20240331 | Net Income Loss | -357071.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | |||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 2805774.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable; Related Party Transactions By Related Party= Management And Board Of Directors; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 67500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable Three; | ||
| 0001641172-25-009392 | 20240331 | Operating Expenses | 202338.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Other Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Advances Related Parties; | ||
| 0001641172-25-009392 | 20241231 | Proceeds From Related Party Debt | 7116.0000 | USD | 4 | us-gaap/2024 | Related Party Transaction= Advances Related Parties; | ||
| 0001641172-25-009392 | 20231231 | Stockholders Equity | -12029311.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20231231 | Stockholders Equity | 25789908.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009392 | 20240331 | Stockholders Equity | -12386382.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Stockholders Equity | -38216675.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | 1449.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 437704501.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Additional Paid In Capital Common Stock | 26323638.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Assets | 20251.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Cash | 169832.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 1132.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock Value | 44534.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 76583.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | |||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 2805774.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-009392 | 20250331 | Operating Expenses | 532142.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Operating Income Loss | -532142.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Other Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Advances Related Parties; | ||
| 0001641172-25-009392 | 20241231 | Prepaid Expense And Other Assets Current | 112.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Proceeds From Related Party Debt | USD | 1 | us-gaap/2024 | Related Party Transaction= Advances Related Parties; | |||
| 0001641172-25-009392 | 20231231 | Stockholders Equity | -37859604.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20240331 | Stockholders Equity | 40835.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20240331 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | |||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | 26323638.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | -99000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001641172-25-009392 | 20241231 | Stock Issued During Period Shares New Issues | 14490000.0000 | shares | 4 | us-gaap/2024 | Type Of Arrangement= Equity Transactions Two Thousand Twenty Three; | ||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Shares New Issues | 14490000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | -99000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | ||
| 0001641172-25-009392 | 20241231 | Assets Current | 20251.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Assets Current | 221456.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 20139.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | 149693.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Mr Jones; Type Of Arrangement= Employment Agreement; | ||
| 0001641172-25-009392 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.1000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; Range= Maximum; Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-009392 | 20241231 | Common Stock Shares Issued | 430837871.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Common Stock Shares Outstanding | 430837871.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Earnings Per Share Basic | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Cash Provided By Used In Financing Activities | 476000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | -683641.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Subscription Receivable; | |||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 60000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable Two; | ||
| 0001641172-25-009392 | 20240331 | Operating Income Loss | -202338.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20231231 | Other Liabilities Current | 31200.0000 | USD | 0 | us-gaap/2024 | Related Party Transaction= Advances Related Parties; | ||
| 0001641172-25-009392 | 20241231 | Shares Outstanding | 430837871.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20240331 | Stockholders Equity | 25789908.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | 44534.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20250430 | Stock Issued During Period Shares New Issues | 8533333.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-009392 | 20241231 | Stock Issued During Period Value New Issues | 455000.0000 | USD | 4 | us-gaap/2024 | Type Of Arrangement= Equity Transactions Two Thousand Twenty Three; | ||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | 476000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | 20000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001641172-25-009392 | 20241231 | Deposit Liability Current | USD | 0 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20250331 | Accounts Payable And Accrued Liabilities Current | 4243019.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009392 | 20241231 | Cash | 20139.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 169832.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Convertible Notes Payable Current | 166667.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Convertible Notes Payable Current | 166667.0000 | USD | 0 | us-gaap/2024 | Short Term Debt Type= Convertible Notes Payable; | ||
| 0001641172-25-009392 | 20250331 | Deposit Liability Current | 310000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Earnings Per Share Diluted | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Increase Decrease In Accounts Payable Related Parties | 198464.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 51512.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Cash Provided By Used In Operating Activities | -326307.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | |||
| 0001641172-25-009392 | 20240331 | Net Income Loss | USD | 1 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | |||
| 0001641172-25-009392 | 20240331 | Nonoperating Income Expense | -154733.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable; | ||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 2805774.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable; Related Party Transactions By Related Party= Management And Board Of Directors; | ||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= In Default; | ||
| 0001641172-25-009392 | 20241231 | Other Liabilities Current | 2500.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Accounts Payable And Accrued Liabilities Current | 4166436.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009392 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -1132.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock Shares Authorized | 500000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Income Taxes Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 156825.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Interest Expense Debt Excluding Amortization | 154733.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Net Income Loss | -683641.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 2805774.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Related Party; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 60000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable Two; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 652500.0000 | USD | 0 | us-gaap/2024 | Related Party Transactions By Related Party= Nonrelated Party; | ||
| 0001641172-25-009392 | 20240331 | Proceeds From Issuance Of Common Stock | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20240331 | Proceeds From Related Party Debt | 650.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Shares Outstanding | 445327871.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | |||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | 553551.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009392 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 403844204.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | General And Administrative Expense | 202338.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Increase Decrease In Accounts Payable Related Parties | 22263.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Interest Expense Debt Excluding Amortization | 151499.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Liabilities And Stockholders Equity | 221456.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Proceeds From Related Party Debt | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20250331 | Research And Development Expense | 142793.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | 26877189.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | 20000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock To Be Issued; | ||
| 0001641172-25-009392 | 20250331 | Stockholders Equity | -40056813.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001641172-25-009392 | 20250331 | Stock Issued During Period Value New Issues | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | |||
| 0001641172-25-009392 | 20241231 | Subscription Receivable | USD | 0 | 0001641172-25-009392 | ||||
| 0001641172-25-009392 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 403844204.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 437704501.0000 | shares | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Assets | 221456.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250430 | Common Stock Par Or Stated Value Per Share | 0.0250 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; Range= Minimum; Subsequent Event Type= Subsequent Event; | ||
| 0001641172-25-009392 | 20241231 | Common Stock To Be Issued | USD | 0 | 0001641172-25-009392 | ||||
| 0001641172-25-009392 | 20241231 | Common Stock Value | 43085.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | General And Administrative Expense | 389349.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20240331 | Interest Paid Net | USD | 1 | us-gaap/2024 | ||||
| 0001641172-25-009392 | 20250331 | Interest Paid Net | 97042.0000 | USD | 1 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20241231 | Notes Payable Current | 67500.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable Three; | ||
| 0001641172-25-009392 | 20250331 | Notes Payable Current | 525000.0000 | USD | 0 | us-gaap/2024 | Debt Instrument= Notes Payable One; | ||
| 0001641172-25-009392 | 20241231 | Retained Earnings Accumulated Deficit | -39373172.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20250331 | Retained Earnings Accumulated Deficit | -40056813.0000 | USD | 0 | us-gaap/2024 | |||
| 0001641172-25-009392 | 20231231 | Shares Outstanding | 403844204.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20240331 | Shares Outstanding | 403844204.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20231231 | Stockholders Equity | 40385.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001641172-25-009392 | 20241231 | Stockholders Equity | USD | 0 | us-gaap/2024 | Equity Components= Subscription Receivable; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable and Accrued Liabilities, Current | Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. |
| Increase Decrease In Customer Deposits | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Customer Deposits | The increase (decrease) during the period in the amount of customer money held in customer accounts, including security deposits, collateral for a current or future transactions, initial payment of the cost of acquisition or for the right to enter into a contract or agreement. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Deposit Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Deposit Liability, Current | The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Convertible Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Convertible Notes Payable, Current | Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Common Stock To Be Issued | 0001641172-25-009392 | 1 | 0 | monetary | I | C | Common stock to be issued | Common stock to be issued. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Other Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Current | Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer. |
| Subscription Receivable | 0001641172-25-009392 | 1 | 0 | monetary | I | C | Subscription receivable | Subscription receivable. |
| Interest Expense Debt Excluding Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Debt, Excluding Amortization | Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Notes Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Increase Decrease In Accounts Payable Related Parties | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable, Related Parties | The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence. |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Research And Development Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense | Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Stock Issued During Period Shares New Issues | us-gaap/2024 | 0 | 0 | shares | D | Stock Issued During Period, Shares, New Issues | Number of new stock issued during the period. | |
| Additional Paid In Capital Common Stock | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Proceeds From Related Party Debt | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Related Party Debt | The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates. |
| Stock Issued During Period Value New Issues | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001641172-25-009392 | 2 | 9 | BS | 0 | H | Cash | us-gaap/2024 | Cash | 0 |
| 0001641172-25-009392 | 2 | 10 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaids and other | 0 |
| 0001641172-25-009392 | 2 | 11 | BS | 0 | H | Assets Current | us-gaap/2024 | Total Current Assets | 0 |
| 0001641172-25-009392 | 2 | 12 | BS | 0 | H | Assets | us-gaap/2024 | Total Assets | 0 |
| 0001641172-25-009392 | 2 | 15 | BS | 0 | H | Accounts Payable And Accrued Liabilities Current | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-009392 | 2 | 16 | BS | 0 | H | Notes Payable Current | us-gaap/2024 | Notes payable | 0 |
| 0001641172-25-009392 | 2 | 17 | BS | 0 | H | Convertible Notes Payable Current | us-gaap/2024 | Convertible note payable - net | 0 |
| 0001641172-25-009392 | 2 | 18 | BS | 0 | H | Other Liabilities Current | us-gaap/2024 | Advances - others | 0 |
| 0001641172-25-009392 | 2 | 19 | BS | 0 | H | Deposit Liability Current | us-gaap/2024 | Customer deposits | 0 |
| 0001641172-25-009392 | 2 | 20 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total Current Liabilities | 0 |
| 0001641172-25-009392 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock - $0.0001 par value, 500,000,000 shares authorized 445,327,871 and 430,837,871 shares issued and outstanding, respectively | 0 |
| 0001641172-25-009392 | 2 | 23 | BS | 0 | H | Common Stock To Be Issued | 0001641172-25-009392 | Common stock to be issued | 0 |
| 0001641172-25-009392 | 2 | 24 | BS | 0 | H | Additional Paid In Capital Common Stock | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001641172-25-009392 | 2 | 25 | BS | 0 | H | Subscription Receivable | 0001641172-25-009392 | Subscription receivable | 0 |
| 0001641172-25-009392 | 2 | 26 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001641172-25-009392 | 2 | 27 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total Stockholders Deficit | 0 |
| 0001641172-25-009392 | 2 | 28 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total Liabilities and Stockholders Deficit | 0 |
| 0001641172-25-009392 | 3 | 1 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value | 0 |
| 0001641172-25-009392 | 3 | 2 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized | 0 |
| 0001641172-25-009392 | 3 | 3 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued | 0 |
| 0001641172-25-009392 | 3 | 4 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding | 0 |
| 0001641172-25-009392 | 4 | 2 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative expenses | 0 |
| 0001641172-25-009392 | 4 | 3 | IS | 0 | H | Research And Development Expense | us-gaap/2024 | Research and development | 0 |
| 0001641172-25-009392 | 4 | 4 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001641172-25-009392 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001641172-25-009392 | 4 | 7 | IS | 0 | H | Interest Expense Debt Excluding Amortization | us-gaap/2024 | Interest expense | 1 |
| 0001641172-25-009392 | 4 | 8 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Total other expense | 0 |
| 0001641172-25-009392 | 4 | 9 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009392 | 4 | 10 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Loss per share - basic | 0 |
| 0001641172-25-009392 | 4 | 11 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Loss per share - diluted | 0 |
| 0001641172-25-009392 | 4 | 12 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average number of shares - basic | 0 |
| 0001641172-25-009392 | 4 | 13 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average number of shares - diluted | 0 |
| 0001641172-25-009392 | 5 | 10 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009392 | 5 | 11 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009392 | 5 | 12 | EQ | 0 | H | Stock Issued During Period Value New Issues | us-gaap/2024 | Stock issued for cash | 0 |
| 0001641172-25-009392 | 5 | 13 | EQ | 0 | H | Stock Issued During Period Shares New Issues | us-gaap/2024 | Stock issued for cash, shares | 0 |
| 0001641172-25-009392 | 5 | 14 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009392 | 5 | 15 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001641172-25-009392 | 5 | 16 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance, shares | 0 |
| 0001641172-25-009392 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001641172-25-009392 | 6 | 5 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaids and other | 1 |
| 0001641172-25-009392 | 6 | 7 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable and accrued expenses | 0 |
| 0001641172-25-009392 | 6 | 8 | CF | 0 | H | Increase Decrease In Accounts Payable Related Parties | us-gaap/2024 | Accounts payable and accrued expenses - related parties | 0 |
| 0001641172-25-009392 | 6 | 9 | CF | 0 | H | Increase Decrease In Customer Deposits | us-gaap/2024 | Customer deposits | 0 |
| 0001641172-25-009392 | 6 | 10 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001641172-25-009392 | 6 | 12 | CF | 0 | H | Proceeds From Related Party Debt | us-gaap/2024 | Proceeds from advances - related parties | 0 |
| 0001641172-25-009392 | 6 | 13 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from stock issued for cash | 0 |
| 0001641172-25-009392 | 6 | 14 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Cash provided by financing activities | 0 |
| 0001641172-25-009392 | 6 | 15 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash | 0 |
| 0001641172-25-009392 | 6 | 16 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - beginning of period | 0 |
| 0001641172-25-009392 | 6 | 17 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash - end of period | 0 |
| 0001641172-25-009392 | 6 | 19 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001641172-25-009392 | 6 | 20 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income tax | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |